« back to directory

Company Profile

Carina Biotech

  •  
  •  

About Carina Biotech

Carina Biotech is a spin-out company from the CRC for Cell Therapy Manufacturing (CTM@CRC Ltd). Carina serves as an IP development and commercialisation vehicle for T-cell immunotherapy related technologies, in particular, chimeric antigen receptor T cell (CAR-T) technologies.

Carina seeks to:

  • Expand the clinical indications for T cell therapiesby developing new CAR-T cells for solid tumours, including paediatric cancers
  • Improve the commercial viability of T cell therapies by developing supporting technologies that make T cell therapies more effective or economically viable